Galleri® Cancer Screening offered by Nonkulie Dladla, M.D. provides patients in Manhattan, New York a groundbreaking solution for early cancer detection.
Benefits of Galleri® Cancer Screening
OVERVIEW
About Galleri® Cancer Screening
Who is a Candidate?
Patients in New York and surrounding areas are ideal candidates for Galleri® Cancer Screening. This includes:
- Adults aged 50 and older, who are at higher risk for cancer.
- Individuals with a family history of cancer or genetic predispositions.
- Patients seeking a proactive approach to their health, even without symptoms.
- Those ineligible for traditional cancer screenings or concerned about multi-cancer detection.
Procedure Description
With Nonkulie Dladla, M.D., the process is simple and patient-focused:
- Blood Draw: Nonkulie Dladla, M.D. collects a sample for this blood-based cancer test, which is then sent to a specialized lab.
- cfDNA Analysis: The sample is analyzed for methylation patterns associated with cancer, making it a leading method in advanced cancer diagnostics.
- Results Delivery: Patients and their doctors receive results within 10 business days, detailing any detected cancer signals and their potential tissue of origin.
- Next Steps: If a cancer signal is detected, follow-up diagnostic evaluations with Nonkulie Dladla, M.D. are recommended.
CANCERS DETECTED
Types of Cancers Detected
Galleri® Cancer Screening effectively detects early signals of:
- Pancreatic Cancer: Detects cfDNA signals indicative of pancreatic tumors, providing early pancreatic cancer detection.
- Liver Cancer: Identifies abnormal methylation patterns related to hepatocellular carcinoma.
- Ovarian Cancer: Provides early ovarian cancer screening.
- Lung Cancer: Screens for markers of non-small cell lung cancer.
- Esophageal Cancer: Aids in detecting esophageal adenocarcinoma.
- Colorectal Cancer: Complements existing colonoscopy protocols with early detection capabilities.
FAQs
Galleri® Cancer Screening FAQs
What is Galleri® Cancer Screening?
Galleri® is a multi-cancer early detection test offered by Nonkulie Dladla, M.D. in New York, New York, that screens for over 50 types of cancers by analyzing cfDNA methylation patterns.
How does the test work?
It detects abnormal DNA patterns shed by tumors into the bloodstream, identifying potential cancer signals.
Is the test safe?
Yes, Galleri® is a simple, non-invasive cancer screening test with no associated risks, available conveniently by Nonkulie Dladla, M.D..
Who should consider this test?
Adults aged 50 or older, individuals with increased cancer risks, or anyone seeking proactive cancer screening in Manhattan.
Does it replace other cancer screenings?
No, Galleri® is designed to complement—not replace—current cancer screening methods.
How accurate is the test?
The test demonstrates high sensitivity and specificity for multiple cancer types, making it a valuable tool in advanced cancer diagnostics.
When will I get results?
Results are typically available within 10 business days.
What happens if a cancer signal is detected?
Nonkulie Dladla, M.D. will recommend further diagnostic evaluations to confirm and locate the cancer.
Protect Your Health with Galleri® Cancer Screening
Systems-Based Care That Connects the Dots
Integrative medicine at Gramercy Park Longevity & Regenerative Medicine Center is not alternative; it’s advanced, thoughtful, and whole. Nonkulie Dladla, M.D. blends the best of modern diagnostics with proven therapies across nutrition, botanicals, mind-body techniques, and lifestyle redesign. Your care is collaborative, intentional, and built on what actually supports healing. We don’t choose between science and intuition; we use both. Because true wellness isn’t either/or, it’s everything working together, in the right sequence, at the right time.
For those seeking deeper emotional and energetic healing, Nonkulie Dladla, M.D. also offers The Kailo Method™, a proprietary system that includes breathwork, somatic release, NLP coaching, nervous system rewiring, and emotional detox therapies designed to support healing at every level of the human experience.